The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Merck Sharp & Dohme Oncology
Stock and Other Ownership Interests - Abbott; Abbvie; Bristol-Myers Squibb; Johnson & Johnson; Merck Sharp & Dohme Oncology
Healthcare resource utilization (HRU) and costs among patients with Von Hippel-Lindau disease (VHL)-associated renal cell carcinoma (RCC): A retrospective administrative claims analysis.
 
Eric Jonasch
Consulting or Advisory Role - aravive; Calithera Biosciences; Eisai; Exelixis; Merck; NiKang Therapeutics; Novartis; Pfizer
Research Funding - Aravive; Novartis; Peloton Therapeutics
Travel, Accommodations, Expenses - Pfizer
 
Yan Song
Research Funding - Merck (Inst)
 
Jonathan Freimark
Research Funding - Merck (Inst)
 
Richard Berman
Research Funding - Merck (Inst)
 
Ha Nguyen
Research Funding - Merck (Inst)
 
James Signorovitch
Research Funding - Merck (Inst)
 
Murali Sundaram
No Relationships to Disclose